PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results
Go back to PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results| PTC THERAPEUTICS (NASDAQ: PTCT) | Delayed: 65.26 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $65.26 | 52 Week High | $35.40 | |||
| Open | $65.26 | 52 Week Low | $4.03 | |||
| Day High | $65.26 | P/E | 6.94 | |||
| Day Low | $65.26 | EPS | $9.40 | |||
| Volume | 12,108 | |||||
